Trial Profile
A phase III study of remimazolam in procedural sedation
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 07 Dec 2018 New trial record